PTEN and neoplasm: The majority of samples for determination of PIK3CA/AKT1/PTEN status were from primary tumor tissue (143 [64%] primary, 66 [30%] metastatic, 10 [5%] unknown, three [1%] enrolled based on local testing with no central confirmation available).